Go to:http://www.foiservices.com and use Isbill in the search box.

You will get a list of reports like this; select the report you want and download it.

All the bold reports involve full reports of clinical research audits. This list contains only reports that FOIServices
has purchased. The list is incomplete; noticeably, there are no European inspection reports.

103626A: Griffith Microscience, Bound Brook, NJ, USA: EIR; 483 11/29/1990 - 12/05/1990
166658A: Scott Dorfner, Burlington, New Jersey: EIR, 483 10/26/1999-11/23/1999
165217A: Bristol Myers Squibb, Lawrenceville, New Jersey: EIR 03/09-15/2000
161284A: Novo Nordisk , Princeton, NJ, USA: Establishment Inspection Report (EIR) 10/08/1999 - 10/08/1999
5207016D: Home Diagnostics, Eatontown, New Jersey: EIR, 483, Company Response 05/11-14/1992
5223669B: David Hassman, Berlin, New Jersey: EIR, 483 07/09-31/2001
123132A: CP Packaging, Jamesburg, NJ, USA: EIR, 483 02/06/1992 - 02/14/1992
5228582C: Harry Collins, Edison, New Jersey: EIR 03/18-27/1997
161122A: ClinCon Research, Chester, New Jersey: EIR, 483, Warning Letter 7/20-10/6/1998
5203350D: Siemens Medical Systems, Iselin, New Jersey: 481 9/17/1992
5214445J: MDS Pharma Services, Saint Laurent, Canada: EIR 12/18-21/2000
WL202059A: Comprehensive Clinical Research: 06/05/2002 Warning Letter Re New Drug Studies
154434A: Phoenix International, St. Laurent, Canada: EIR 10/27/1997 - 11/07/1997
5221509H: Pharmaco, East Millstone, New Jersey: EIR EIR, 483 02/07-09/1995
5216771B: Integra Lifesciences Corp, Plainsboro, New Jersey: EIR 03/30/1999
166658B: Scott Dorfner, Burlington, New Jersey: EIR, 483, Warning Letter, Correspondence, 10/26-11/23/1999
5214874B: Michael Gallagher, Moorestown, New Jersey: EIR 11/02-03/2000
5228581B: David Hassman, Berlin, New Jersey: EIR, 483, Warning Letter 07/09-31/2001
166659A: Stanley Markunas, Burlington, New Jersey: EIR 10/14-20/1999
5205373B: RW Johnson Pharmaceutical Research Institute, Raritan, New Jersey: EIR 03/08/1995
5214500C: Centurion Systems, Edison, New Jersey: EIR 10/08/2003
151986A: Phoenix International, Saint Laurent, Canada: EIR 10/27-11/07/1997
140419A: Merck, Iselin, NJ, USA: EIR, 483, COMPANY RESPONSE 01/10/1995 - 01/17/1995
160898A: Daiichi Pharmaceuticals, Fort Lee, NJ, US: EIR Summary 09/09/1998 - 10/16/1998
5226764D: RW Johnson Pharmaceutical Research Institute, Raritan, New Jersey: EIR, Response 09/24/1998
5206867A: David Hassman, Berlin, New Jersey: EIR, 483, Warning Letter 07/09-31/2001